Retained Earnings
Vertex Pharmaceuticals Retained Earnings increased by 9.6% to $13.56B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 41.2%, from $9.61B to $13.56B. Over 5 years (FY 2020 to FY 2025), Retained Earnings shows an upward trend with a 73.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Consistent growth in retained earnings signals a profitable business model that can sustain itself without constant external capital raises.
Detailed definition
The cumulative amount of net income that has been reinvested in the business rather than distributed to shareholders as...
Peer comparison
Mature, highly profitable companies like Apple may actually see this decrease if they return more cash to shareholders via buybacks than they earn in net income.
retained_earningsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.58B | $2.43B | $3.20B | $3.96B | $4.77B | $5.70B | $6.52B | $7.22B | $8.14B | $9.17B | $10.14B | $11.24B | $7.65B | $8.69B | $9.61B | $10.25B | $11.29B | $12.37B | $13.56B |
| QoQ Change | — | +54.0% | +31.7% | +23.8% | +20.5% | +19.5% | +14.4% | +10.7% | +12.7% | +12.7% | +10.6% | +10.8% | -32.0% | +13.7% | +10.5% | +6.7% | +10.1% | +9.6% | +9.6% |
| YoY Change | — | — | — | — | +202.4% | +134.7% | +103.8% | +82.3% | +70.5% | +60.8% | +55.5% | +55.7% | -6.0% | -5.2% | -5.3% | -8.8% | +47.6% | +42.3% | +41.2% |
Retained Earnings at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's retained earnings?
- Vertex Pharmaceuticals (VRTX) reported retained earnings of $13.56B in Q4 2025.
- How has Vertex Pharmaceuticals's retained earnings changed year-over-year?
- Vertex Pharmaceuticals's retained earnings increased by 41.2% year-over-year, from $9.61B to $13.56B.
- What is the long-term trend for Vertex Pharmaceuticals's retained earnings?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's retained earnings has grown at a 73.7% compound annual growth rate (CAGR), from $858.67M to $13.56B.
- What does retained earnings mean?
- The total profits the company has kept and reinvested since it started, after paying out any dividends.